GB0206203D0 - Use - Google Patents

Use

Info

Publication number
GB0206203D0
GB0206203D0 GB0206203A GB0206203A GB0206203D0 GB 0206203 D0 GB0206203 D0 GB 0206203D0 GB 0206203 A GB0206203 A GB 0206203A GB 0206203 A GB0206203 A GB 0206203A GB 0206203 D0 GB0206203 D0 GB 0206203D0
Authority
GB
United Kingdom
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0206203A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cyclacel Ltd
Original Assignee
Cyclacel Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cyclacel Ltd filed Critical Cyclacel Ltd
Priority to GB0206203A priority Critical patent/GB0206203D0/en
Publication of GB0206203D0 publication Critical patent/GB0206203D0/en
Priority to US10/507,883 priority patent/US20050164976A1/en
Priority to AU2003216810A priority patent/AU2003216810A1/en
Priority to CNA038109999A priority patent/CN1652844A/en
Priority to JP2003576050A priority patent/JP2005526086A/en
Priority to PCT/GB2003/001076 priority patent/WO2003077999A1/en
Priority to MXPA04009012A priority patent/MXPA04009012A/en
Priority to EP03712345A priority patent/EP1485168A1/en
Ceased legal-status Critical Current

Links

GB0206203A 2002-03-15 2002-03-15 Use Ceased GB0206203D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GB0206203A GB0206203D0 (en) 2002-03-15 2002-03-15 Use
US10/507,883 US20050164976A1 (en) 2002-03-15 2003-03-14 Combination of a cdk inhibitor and 5-fu for the tratment of cancer
AU2003216810A AU2003216810A1 (en) 2002-03-15 2003-03-14 Combination ofa cdk inhibitor and 5-fu for the treatment of cancer
CNA038109999A CN1652844A (en) 2002-03-15 2003-03-14 Combination of a CDK inhibitor and 5-FU for the treatment of cancer
JP2003576050A JP2005526086A (en) 2002-03-15 2003-03-14 Combination of CDK inhibitor and 5-FU for the treatment of cancer
PCT/GB2003/001076 WO2003077999A1 (en) 2002-03-15 2003-03-14 Combination ofa cdk inhibitor and 5-fu for the treatment of cancer
MXPA04009012A MXPA04009012A (en) 2002-03-15 2003-03-14 Combination ofa cdk inhibitor and 5-fu for the treatment of cancer.
EP03712345A EP1485168A1 (en) 2002-03-15 2003-03-14 Combination of a cdk inhibitor and 5-fu for the treatment of cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0206203A GB0206203D0 (en) 2002-03-15 2002-03-15 Use

Publications (1)

Publication Number Publication Date
GB0206203D0 true GB0206203D0 (en) 2002-05-01

Family

ID=9933082

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0206203A Ceased GB0206203D0 (en) 2002-03-15 2002-03-15 Use

Country Status (1)

Country Link
GB (1) GB0206203D0 (en)

Similar Documents

Publication Publication Date Title
PL372902A1 (en) New use
GB0227666D0 (en) Use
GB0206048D0 (en) Use
AU2003249738A8 (en) Ostoscope
AU2003297193A8 (en) Meta-web
AU2003252028A8 (en) Heterodiamondoids
AU2003279495A8 (en) Alert-modeling
GB0217056D0 (en) Use
GB0213878D0 (en) Use
AU2003264900A8 (en) Cast-cutter
AU2002367810A8 (en) Bis-transition-metal-chelate-probes
GB0206838D0 (en) Use
AU2003262681A8 (en) Hemo-aide
GB0230343D0 (en) Use
GB0204720D0 (en) Novel use
AU2003253735A8 (en) Vacuolins
AU2002341221A8 (en) Honey-brandy
GB0210682D0 (en) Novel use
GB0229442D0 (en) Use
GB0225876D0 (en) Use
GB0220135D0 (en) Use
GB0214802D0 (en) Use
GB0207228D0 (en) Use
GB0222408D0 (en) Use
GB0206203D0 (en) Use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)